Search

UCB SA

Closed

SectorHealthcare

204.1 0.44

Overview

Share price change

24h

Current

Min

203.2

Max

204.5

Key metrics

By Trading Economics

Income

28M

1.1B

Sales

16M

4.3B

P/E

Sector Avg

18.012

48.735

EPS

5.7

Dividend yield

0.71

Profit margin

26.019

Employees

9,000

EBITDA

899M

1.7B

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+19.23% upside

Dividends

By Acuity

Dividend yield

Sector Avg

0.71%

2.24%

Market Stats

By TradingEconomics

Market Cap

-8B

39B

Previous open

203.66

Previous close

204.1

UCB SA Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

18 paź 2026, 23:32 UTC

News

Arthur Hayes stated on social media that quantum computing should not deter Bitcoin investment and cautioned against the security risks of reusing wallet addresses.

18 paź 2026, 23:32 UTC

Macro News
News

Bitcoin is trading modestly higher, with Arthur Hayes noting that quantum computing concerns shouldn't deter investors from holding the asset.

18 paź 2026, 20:01 UTC

News

Ethereum is trading lower, continuing a downward trend amid a broader selloff in technology stocks due to concerns over AI financing and inflation data.

18 paź 2026, 20:01 UTC

News

Ethereum is trading lower, continuing a downward trend amid a broader selloff in technology stocks due to concerns over AI financing and inflation data.

17 paź 2026, 22:01 UTC

News

Ethereum is trading lower, continuing a downward trend amid broader market weakness in technology stocks and concerns over AI financing issues.

17 paź 2026, 22:01 UTC

News

Ethereum is trading lower, continuing a downward trend amid broader market weakness in technology stocks due to concerns over AI financing issues.

17 paź 2026, 00:02 UTC

News

Tesla Inc shares are lower in after-market hours as analyst Gary Black cautions against overhyping a potential merger with SpaceX.

17 paź 2026, 00:02 UTC

Social Media
News

Morgan Stanley lowers Netflix's price target to $80 from $83, citing stagnant viewing hours and concerns about engagement trends ahead of next week's earnings report.

17 paź 2026, 00:02 UTC

News

Fastenal Co's stock advanced in after-market trading, supported by a 15.5% sales increase highlighted during its recent earnings call.

17 paź 2026, 00:02 UTC

Social Media
News

Bank of America shares were roughly flat in after-market trading, following a 7-8% decline post-earnings amid analyst concerns over regulatory costs and profitability targets.

17 paź 2026, 00:01 UTC

News

RTX Corp's Raytheon unit secured a $729 million contract for the UAS Integrated Defeat System, contributing to higher shares in after-market hours.

17 paź 2026, 00:01 UTC

News

Shah Capital has withdrawn its investment adviser registration and reduced its stake in Novavax, selling 2.87 million shares at $11.35 each.

17 paź 2026, 00:01 UTC

News

Lyft shares declined in after-market trading as the company announced the launch of Alcove, a new chauffeur brand targeting premium corporate transportation.

17 paź 2026, 00:01 UTC

News

General Electric Co shares are slightly lower in after-market trading amid broader market fluctuations, despite securing a deal for over 300 LEAP-1B engines with CFM International.

17 paź 2026, 00:01 UTC

Correlated Moves
News

Coinbase Global Inc shares are trading modestly lower in after-market hours, reflecting a decline in the broader cryptocurrency market and Bitcoin's slight drop.

17 paź 2026, 00:01 UTC

News

Boeing secures up to $80 million contract from the U.S. Navy for MQ-25A Stingray support, while sales chief McMullen announces retirement.

16 paź 2026, 23:52 UTC

News

Dell Technologies Inc shares are moving lower in after-market hours amid inflation concerns affecting tech valuations, despite being named a core AI partner for Honeywell.

16 paź 2026, 23:51 UTC

News

Baker Hughes Co. has a market capitalization of approximately $54.96 billion, experiencing a modest increase in after-market trading following Friday's close.

16 paź 2026, 23:46 UTC

News

Scholar Rock grants inducement equity awards for 61.02k shares to new employees as part of its strategy to attract talent for ISEMBLYD commercialization.

16 paź 2026, 23:46 UTC

News

Apollo Commercial Real Estate Finance Inc. plans to voluntarily delist from the NYSE, with the last trading day expected on November 6, 2026.

16 paź 2026, 23:41 UTC

News

General Electric Co shares are moving lower in after-market trading following a deal with CFM International for over 300 LEAP-1B engines for Turkish Airlines.

16 paź 2026, 23:41 UTC

News

Boeing Co. secures an $80 million contract from the U.S. Navy for the MQ-25A Stingray unmanned aircraft system, expected to be completed by October 2031.

16 paź 2026, 23:41 UTC

News

Tesla Inc shares are trading modestly lower in after-market hours, continuing a trend of decline and remaining significantly below their 20-day moving average.

16 paź 2026, 23:36 UTC

News

Hingham Institution for Savings reports third-quarter net income of $12.67 million, a decline from $17.30 million year-over-year, with overall performance metrics indicating a decrease.

16 paź 2026, 23:31 UTC

News

Celanese announces global price increases for LCP products, citing strong demand and rising costs, as shares decline in after-market trading.

16 paź 2026, 23:31 UTC

Correlated Moves
News

Coinbase Global Inc shares are trading modestly lower in after-market hours, influenced by a decline in Bitcoin prices and broader market trends.

16 paź 2026, 23:16 UTC

News

In after-market trading, Steel Dynamics Inc is rising, with analysts expecting earnings of approximately $5.40 per share on revenue of around $6.57 billion.

16 paź 2026, 23:12 UTC

Social Media
News

Morgan Stanley lowers Netflix's price target to $80 from $83, citing stagnant viewing hours and concerns over engagement trends ahead of earnings report.

16 paź 2026, 23:11 UTC

News

Lyft Inc shares declined in after-market trading following the announcement of its new premium chauffeur brand, Alcove, amid broader market weakness.

16 paź 2026, 23:11 UTC

News

RTX Corp's Raytheon business secured a $729 million contract for the Ku-band Radio Frequency Sensor and Coyote interceptor, boosting shares higher in after-market hours.

Peer Comparison

Price change

UCB SA Forecast

Price Target

By TipRanks

19.23% upside

12 Months Forecast

Average 94.86 EUR  19.23%

High 125 EUR

Low 74 EUR

Based on 7 Wall Street analysts offering 12 month price targets forUCB SA - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

7 ratings

4

Buy

1

Hold

2

Sell

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About UCB SA

UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide. The company's primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; Neupro for Parkinson's disease and restless legs syndrome; Nayzilam, a nasal spray rescue treatment for epilepsy seizure clusters; and Zyrtec and Xyzal for allergies. It also offers Evenity for the treatment of osteoporosis in postmenopausal women; Bimzelx for treating plaque psoriasis, psoriatic arthritis, and axial spondyloarthritis; and Fintepla to treat Dravet syndrome. In addition, the company is involved in developing rozanolixizumab and Zilbrisq to treat myasthenia gravis; dapirolizumab pegol for systemic lupus erythematosus; fenfluramine to treat CDKL5 deficiency disorder; doxecitine for TK2 deficiency disorder; STACCATO alprazolam for stereotypical prolonged seizures; bepranemab to treat Alzheimer's disease; minzasolmin and UCB0222 for Parkinson's disease; and UCB1381 and UCB9741 for atropic dermatitis. Further, it engages in contract manufacturing activities. UCB SA has collaboration agreements with Amgen, Biogen, Roche/Genentech, Novartis, and Otsuka. The company was incorporated in 1925 and is headquartered in Brussels, Belgium.
help-icon Live chat